サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1451647

医薬品ガラス包装市場レポート：製品タイプ、薬剤タイプ、用途、地域別、2024-2032

Pharmaceutical Glass Packaging Market Report by Product (Bottles, Vials, Ampoules, Cartridges and Syringes, and Others), Drug Type (Generic, Branded, Biologic), Application (Oral, Injectable, Nasal, and Others), and Region 2024-2032

出版日
発行
IMARC
ページ情報
英文 146 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
医薬品ガラス包装市場レポート：製品タイプ、薬剤タイプ、用途、地域別、2024-2032
出版日: 2024年03月02日
発行: IMARC
ページ情報: 英文 146 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の医薬品ガラス包装市場規模は2023年に94億米ドルに達しました。今後、IMARC Groupは、2024年から2032年にかけて6.2%の成長率（CAGR）を示し、2032年には164億米ドルに達すると予測しています。医薬品需要の増加、規制当局が医薬品包装に課す厳しい規制と品質基準、製品の安全性と完全性への注目の高まり、代替材料に対するガラスの優位性に関する意識の高まりなどが、市場を後押しする要因の一部となっています。

医薬品ガラス包装は、医薬品の安全性、完全性、有効性を確保する上で極めて重要です。特別に設計されたガラス容器やクロージャーを使用し、湿気、光、化学的相互作用など、医薬品の品質を損なう可能性のある外的要因から医薬品を保護します。ガラス容器は、優れたバリア性、不活性、透明性など数多くの利点があり、内容物を目視で確認することができます。また、ガラス容器は温度変化に強く、保存期間が長いため、医薬品の保存や保管に最適です。さらに、ガラスは非反応性素材であるため、溶出や汚染のリスクを最小限に抑え、医薬品の安定性と純度を維持することができます。ガラスの多用途性により、バイアル、アンプル、ボトル、シリンジなど様々な包装オプションが可能で、様々な剤形や投与経路に対応しています。医薬品ガラス包装は、医薬品の安全性と信頼性を確保するために厳格な品質管理措置と規制基準の対象となっており、患者ケアと製品の完全性に対する製薬業界のコミットメントの重要な要素となっています。

世界市場は、持続可能性が重視されるようになったことが大きな要因となっています。環境意識の高まりに伴い、製薬業界では持続可能な包装ソリューションに対する需要が高まっています。ガラス包装はプラスチックの代替品よりも環境に優しいと考えられています。さらに、生物製剤、ワクチン、遺伝子治療を含むバイオ医薬品分野の急速な成長により、これらの繊細な製品の安定性と有効性を維持できる特殊な包装が必要とされています。ガラス容器は、汚染からの保護に優れ、バイオ医薬品の完全性を保持するため、医薬品ガラス包装の需要を牽引しています。これとは別に、患者の安全性への関心の高まりが市場を活性化しています。さらに、ジェネリック医薬品やOTC医薬品の市場が拡大していることも、医薬品ガラス包装の需要を促進しています。また、ガラス製造技術や包装技術の急速な革新により、医薬品ガラス包装の機能や性能が向上しています。例えば、ガラス成形技術や表面処理の進歩により、ガラス容器の強度や耐久性が向上しています。さらに、RFIDタグや感温ラベルなどのスマートパッケージング機能の統合により、医薬品のトレーサビリティやモニタリングが強化され、ガラスパッケージングソリューションの採用を促進しています。

医薬品ガラス包装市場の動向と促進要因：

偽造防止対策への注目の高まり

偽造防止対策への注目が高まっていることが、市場の成長に大きく寄与しています。偽造医薬品は患者の安全や公衆衛生に重大なリスクをもたらすため、規制当局や製薬会社はこの問題に対抗するための強固な対策を講じる必要に迫られています。ガラス製包装は、複製や改ざんが困難な固有の偽造防止機能を備えており、医薬品にとって理想的な選択肢となっています。さらに、ガラス容器には、認証・識別手段として、ユニークなエンボス加工、ホログラフィック・ラベル、秘密のマーキングなどを組み込むことができます。これらの機能は、医薬品の真正性を確認し、偽造から保護するのに役立ちます。ガラス包装を使用することで、製薬会社は患者やヘルスケアプロバイダーに、彼らが受け取る医薬品が本物で安全であることを保証することができます。さらに、偽造防止対策としてガラス包装が急速に採用されている背景には、患者の健康を守り、ブランドの評判を維持し、規制要件を遵守する必要性があります。偽造防止への注目が高まるにつれ、医薬品ガラス包装の需要は拡大し、市場の拡大に寄与すると予想されます。

世界の医薬品産業の拡大

世界の製薬産業の拡大が市場成長の主な促進要因となっています。製薬業界は、人口増加、ヘルスケア支出の増加、医療の進歩により大きな成長を遂げています。この成長は医薬品の需要増につながり、ひいてはガラス容器を含む包装ソリューションの需要を牽引しています。さらに、ガラス製包装は製薬業界に非常に適した数多くの利点を提供しています。その優れたバリア特性は、湿気、光、化学的相互作用など、品質や安定性を損なう可能性のある外的要因から医薬品を保護します。また、ガラスは不活性であり、医薬品の完全性と純度を保証します。さらに、ガラス容器は透明であるため、内容物を容易に目視することができます。世界の製薬産業の拡大に伴い、医薬品の有効性と安全性を維持する包装ソリューションに対する需要の高まりに対応するため、医薬品ガラス包装に対するニーズが高まっています。その結果、市場は拡大する製薬業界と、信頼性が高く高品質な包装オプションへの要求によって成長を経験しています。

医薬品の保存期間延長ニーズの高まり

医薬品の保存期間を延長するニーズの高まりが市場を活性化しています。いくつかの医薬品、特に繊細な製剤は、効力と効能を維持するために、より長い保存期間が必要です。この点でガラス包装は非常に有利です。ガラス容器は、光、湿気、酸素など、時間の経過とともに医薬品を劣化させる外的要因に対して卓越した保護を提供します。ガラスはこれらの要素の侵入を防ぐ優れたバリア特性を持ち、医薬品の保存期間を延ばすのに役立ちます。さらに、ガラスは不活性であるため、容器との相互作用による影響を受けず、医薬品が安定した状態を保つことができます。また、ガラスはガスや蒸気を通さないため、医薬品の完全性を保つのに役立ちます。さらに、ガラスは非反応性材料であるため、溶出や汚染のリスクを最小限に抑えることができます。その上、製薬業界が医薬品の寿命と品質を確保しようと努力するにつれ、医薬品ガラス包装の需要が増加しています。製薬会社は、医薬品の保存期間を延ばすために必要な保護と安定性を提供するためにガラス容器に依存しており、市場の成長を促進しています。

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 医薬品ガラス包装の世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品別

  • ボトル
    • 市場動向
    • 市場予測
  • バイアル
    • 市場動向
    • 市場予測
  • アンプル
    • 市場動向
    • 市場予測
  • カートリッジとシリンジ
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第7章 市場内訳：医薬品タイプ別

  • ジェネリック
    • 市場動向
    • 市場予測
  • ブランド
    • 市場動向
    • 市場予測
  • バイオロジック
    • 市場動向
    • 市場予測

第8章 市場内訳：用途別

  • 経口
    • 市場動向
    • 市場予測
  • 注射
    • 市場動向
    • 市場予測
  • 経鼻
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳：地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Ardagh Group S.A
    • Beatson Clark
    • Bormioli Pharma S.p.A.
    • Corning Incorporated
    • Gerresheimer AG
    • Nipro Corporation
    • Piramal Enterprises Ltd.
    • Schott AG
    • SGD Pharma
    • Shandong Pharmaceutical Glass Co. Ltd.
    • Sisecam（Turkiye Is Bankasi A.S.）
    • Stolzle-Oberglas GmBH
    • West Pharmaceutical Services Inc.
図表

List of Figures

  • Figure 1: Global: Pharmaceutical Glass Packaging Market: Major Drivers and Challenges
  • Figure 2: Global: Pharmaceutical Glass Packaging Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Pharmaceutical Glass Packaging Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Pharmaceutical Glass Packaging Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Pharmaceutical Glass Packaging Market: Breakup by Drug Type (in %), 2023
  • Figure 6: Global: Pharmaceutical Glass Packaging Market: Breakup by Application (in %), 2023
  • Figure 7: Global: Pharmaceutical Glass Packaging Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Pharmaceutical Glass Packaging (Bottles) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Pharmaceutical Glass Packaging (Bottles) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Pharmaceutical Glass Packaging (Vials) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Pharmaceutical Glass Packaging (Vials) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Pharmaceutical Glass Packaging (Ampoules) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Pharmaceutical Glass Packaging (Ampoules) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Pharmaceutical Glass Packaging (Cartridges and Syringes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Pharmaceutical Glass Packaging (Cartridges and Syringes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Pharmaceutical Glass Packaging (Other Products) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Pharmaceutical Glass Packaging (Other Products) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Pharmaceutical Glass Packaging (Generic) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Pharmaceutical Glass Packaging (Generic) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Pharmaceutical Glass Packaging (Branded) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Pharmaceutical Glass Packaging (Branded) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Pharmaceutical Glass Packaging (Biologic) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Pharmaceutical Glass Packaging (Biologic) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Pharmaceutical Glass Packaging (Oral) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Pharmaceutical Glass Packaging (Oral) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Pharmaceutical Glass Packaging (Injectable) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Pharmaceutical Glass Packaging (Injectable) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Pharmaceutical Glass Packaging (Nasal) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Pharmaceutical Glass Packaging (Nasal) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Pharmaceutical Glass Packaging (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Pharmaceutical Glass Packaging (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: North America: Pharmaceutical Glass Packaging Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: North America: Pharmaceutical Glass Packaging Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: United States: Pharmaceutical Glass Packaging Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: United States: Pharmaceutical Glass Packaging Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Canada: Pharmaceutical Glass Packaging Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Canada: Pharmaceutical Glass Packaging Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Asia-Pacific: Pharmaceutical Glass Packaging Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Asia-Pacific: Pharmaceutical Glass Packaging Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: China: Pharmaceutical Glass Packaging Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: China: Pharmaceutical Glass Packaging Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Japan: Pharmaceutical Glass Packaging Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Japan: Pharmaceutical Glass Packaging Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: India: Pharmaceutical Glass Packaging Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: India: Pharmaceutical Glass Packaging Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: South Korea: Pharmaceutical Glass Packaging Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: South Korea: Pharmaceutical Glass Packaging Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Australia: Pharmaceutical Glass Packaging Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Australia: Pharmaceutical Glass Packaging Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Indonesia: Pharmaceutical Glass Packaging Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Indonesia: Pharmaceutical Glass Packaging Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Others: Pharmaceutical Glass Packaging Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Others: Pharmaceutical Glass Packaging Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Europe: Pharmaceutical Glass Packaging Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Europe: Pharmaceutical Glass Packaging Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Germany: Pharmaceutical Glass Packaging Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Germany: Pharmaceutical Glass Packaging Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: France: Pharmaceutical Glass Packaging Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: France: Pharmaceutical Glass Packaging Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: United Kingdom: Pharmaceutical Glass Packaging Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: United Kingdom: Pharmaceutical Glass Packaging Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Italy: Pharmaceutical Glass Packaging Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Italy: Pharmaceutical Glass Packaging Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Spain: Pharmaceutical Glass Packaging Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Spain: Pharmaceutical Glass Packaging Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Russia: Pharmaceutical Glass Packaging Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Russia: Pharmaceutical Glass Packaging Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Others: Pharmaceutical Glass Packaging Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Others: Pharmaceutical Glass Packaging Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Latin America: Pharmaceutical Glass Packaging Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Latin America: Pharmaceutical Glass Packaging Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Brazil: Pharmaceutical Glass Packaging Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Brazil: Pharmaceutical Glass Packaging Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Mexico: Pharmaceutical Glass Packaging Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Mexico: Pharmaceutical Glass Packaging Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Others: Pharmaceutical Glass Packaging Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Others: Pharmaceutical Glass Packaging Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Middle East and Africa: Pharmaceutical Glass Packaging Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Middle East and Africa: Pharmaceutical Glass Packaging Market: Breakup by Country (in %), 2023
  • Figure 80: Middle East and Africa: Pharmaceutical Glass Packaging Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Global: Pharmaceutical Glass Packaging Industry: SWOT Analysis
  • Figure 82: Global: Pharmaceutical Glass Packaging Industry: Value Chain Analysis
  • Figure 83: Global: Pharmaceutical Glass Packaging Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Pharmaceutical Glass Packaging Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Pharmaceutical Glass Packaging Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Pharmaceutical Glass Packaging Market Forecast: Breakup by Drug Type (in Million US$), 2024-2032
  • Table 4: Global: Pharmaceutical Glass Packaging Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 5: Global: Pharmaceutical Glass Packaging Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Pharmaceutical Glass Packaging Market: Competitive Structure
  • Table 7: Global: Pharmaceutical Glass Packaging Market: Key Players
目次
Product Code: SR112024A5094

The global pharmaceutical glass packaging market size reached US$ 9.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 16.4 Billion by 2032, exhibiting a growth rate (CAGR) of 6.2% during 2024-2032. The increasing demand for pharmaceutical products, the stringent regulations and quality standards imposed by regulatory authorities on pharmaceutical packaging, the rising focus on product safety and integrity, and the growing awareness regarding the advantages of glass over alternative materials are some of the factors propelling the market.

Pharmaceutical glass packaging is crucial in ensuring pharmaceutical products' safety, integrity, and efficacy. It involves using specially designed glass containers and closures to protect drugs from external factors that could compromise their quality, such as moisture, light, and chemical interactions. It offers numerous advantages, including excellent barrier properties, inertness, and transparency, allowing for the visual inspection of the contents. Glass containers also resist temperature changes and have a long shelf life, making them ideal for storing and preserving pharmaceuticals. Additionally, glass is a non-reactive material that minimizes the risks of leaching or contamination, maintaining the stability and purity of medications. The versatility of glass allows for various packaging options, including vials, ampoules, bottles, and syringes, catering to different dosage forms and administration routes. Pharmaceutical glass packaging is subject to stringent quality control measures and regulatory standards to ensure the safety and reliability of medicines, making it a critical component of the pharmaceutical industry's commitment to patient care and product integrity.

The global market is majorly driven by the increasing emphasis on sustainability. With the growing environmental consciousness, there is a rising demand for sustainable packaging solutions in the pharmaceutical industry. Glass packaging is considered to be more environmentally friendly than plastic alternatives. Furthermore, the rapid growth of the biopharmaceutical sector, including biologics, vaccines, and gene therapies, requires specialized packaging that can maintain the stability and efficacy of these sensitive products. Glass containers offer superior protection against contamination and preserve the integrity of biopharmaceuticals, thus driving the demand for pharmaceutical glass packaging. Apart from this, the escalating focus on patient safety is catalyzing the market. Moreover, the expanding market for generic drugs and OTC medications fuels the demand for pharmaceutical glass packaging. Besides, the rapid innovations in glass manufacturing and packaging technologies have improved the capabilities and functionalities of pharmaceutical glass packaging. For instance, advancements in glass forming techniques and surface treatments have enhanced the strength and durability of glass containers. Additionally, the integration of smart packaging features, such as RFID tags and temperature-sensitive labels, provides enhanced traceability and monitoring of pharmaceutical products, driving the adoption of glass packaging solutions.

Pharmaceutical Glass Packaging Market Trends/Drivers:

Increasing focus on anti-counterfeiting measures

The increasing focus on anti-counterfeiting measures is significantly contributing to the market growth. Counterfeit drugs pose significant risks to patient safety and public health, prompting regulatory authorities and pharmaceutical companies to take robust measures to combat this issue. Glass packaging offers inherent anti-counterfeiting features that are difficult to replicate or tamper with, making it an ideal choice for pharmaceutical products. Furthermore, the glass containers can incorporate unique embossing, holographic labels, and covert markings as authentication and identification measures. These features help verify the authenticity of pharmaceutical products and protect them from counterfeiting. By using glass packaging, pharmaceutical companies can assure patients and healthcare providers that the medications they receive are genuine and safe. Moreover, the rapid adoption of glass packaging as an anti-counterfeiting measure is driven by the need to safeguard patient health, maintain brand reputation, and comply with regulatory requirements. As the focus on anti-counterfeiting intensifies, the demand for pharmaceutical glass packaging is expected to grow, thereby contributing to the expansion of the market.

Expanding pharmaceutical industry worldwide

The expanding pharmaceutical industry worldwide is a key driver of the growth in the market. The pharmaceutical sector is experiencing substantial growth due to population growth, increasing healthcare spending, and advancements in medical treatments. This growth translates into a higher demand for pharmaceutical products, which, in turn, drives the demand for packaging solutions, including glass containers. Furthermore, glass packaging offers numerous advantages that make it highly suitable for the pharmaceutical industry. Its excellent barrier properties protect drugs from external factors that could compromise their quality and stability, such as moisture, light, and chemical interactions. Glass is also inert, ensuring the integrity and purity of medications. Additionally, glass containers provide transparency, allowing for easy visual inspection of the contents. With the expansion of the pharmaceutical industry worldwide, there is an increased need for pharmaceutical glass packaging to meet the growing demand for packaging solutions that maintain the efficacy and safety of medications. As a result, the market is experiencing growth, driven by the expanding pharmaceutical industry and its requirements for reliable and high-quality packaging options.

Rising need to extend the shelf life of medicinal products

The rising need to extend the shelf life of medicinal products is catalyzing the market. Several medications, particularly sensitive formulations, require a longer shelf life to maintain their potency and efficacy. Glass packaging is highly advantageous in this regard. Glass containers offer exceptional protection against external factors that can degrade pharmaceutical products over time, such as light, moisture, and oxygen. Glass has excellent barrier properties that prevent the ingress of these elements, helping to extend the shelf life of medications. Furthermore, the inert nature of glass ensures that drugs remain stable and unaffected by interactions with the container. Glass is also impermeable to gases and vapors, which further helps preserve the integrity of pharmaceutical products. Moreover, glass is a non-reactive material, minimizing the risk of leaching or contamination. Besides, as the pharmaceutical industry strives to ensure the longevity and quality of medicinal products, the demand for pharmaceutical glass packaging increases. Pharmaceutical companies rely on glass containers to provide the necessary protection and stability required to extend the shelf life of their medications, thus driving the growth of the market.

Pharmaceutical Glass Packaging Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global pharmaceutical glass packaging market report, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on product, drug type, and application.

Breakup by Product:

Bottles

Vials

Ampoules

Cartridges and Syringes

Others

Bottles dominate the market

The report has provided a detailed breakup and analysis of the market based on product. This includes bottles, vials, ampoules, cartridges and syringes, and others. According to the report, bottles represented the largest segment.

Bottles are widely used in the pharmaceutical industry for packaging liquid medications, such as syrups, suspensions, and oral solutions. The demand for pharmaceutical bottles is driven by the increasing consumption of liquid medications, the need for accurate dosing, and the preference for child-resistant packaging.

On the contrary, vials are primarily used for packaging injectable drugs, including vaccines, biologics, and parenteral medications. The growing demand for biopharmaceuticals and the rise in chronic diseases requiring injectable therapies contribute to expanding the vials segment in the market. Moreover, ampoules are small, sealed glass containers for packaging single-dose injectable drugs. They offer excellent product protection, ensuring sterility and preventing contamination. The need for precise dosing, prolonged shelf life, and the increasing demand for aseptic packaging solutions drive the ampoules segment.

Besides, cartridges and syringes are utilized for packaging and administering pre-filled drugs, such as insulin and other injectables. The convenience, accuracy, and ease of use associated with pre-filled cartridges and syringes contribute to their growing demand, driven by factors such as the rise in chronic diseases and the need for self-administered medications.

Breakup by Drug Type:

Generic

Branded

Biologic

Generic holds the largest share in the market

A detailed breakup and analysis of the market based on the drug type have also been provided in the report. This includes generic, branded, and biologic. According to the report, generic accounted for the largest market share.

The increasing demand for generic drugs, driven by cost-effectiveness and patent expirations, fuels the growth of the market. Generic drugs require reliable and high-quality packaging solutions to maintain their efficacy, stability, and shelf life. Glass containers provide excellent protection against degradation factors, ensuring the integrity and potency of generic medications.

On the other hand, branded drugs, with their unique formulations and therapeutic properties, necessitate specialized packaging to maintain their identity and market appeal. Pharmaceutical glass packaging offers a premium and trustworthy image for branded drugs, enhancing brand recognition and patient confidence. The use of glass containers conveys a sense of quality and reliability to consumers, thus contributing to the market.

Moreover, the increasing prominence of biologics, including vaccines, monoclonal antibodies, and gene therapies, propels the demand for pharmaceutical glass packaging. Biologic drugs are often sensitive to environmental factors and require stringent storage and packaging conditions. Glass containers provide superior protection against light, oxygen, and moisture, ensuring the stability and efficacy of biologic medications.

Breakup by Application:

Oral

Injectable

Nasal

Others

A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes oral, injectable, nasal, and others.

The oral segment involves packaging medications in tablets, capsules, and syrups for ingestion. The demand for pharmaceutical glass packaging in the oral segment is driven by factors such as the increasing consumption of oral medications, the need for moisture and contamination protection, and the preference for child-resistant and tamper-evident packaging.

Furthermore, the injectable segment involves packaging drugs administered via injections, including vaccines, biologics, and parenteral medications. Glass containers are preferred in this segment due to their superior properties in maintaining sterility, preventing contamination, and preserving the stability of injectable drugs. The growth of the injectable segment is fueled by the rise in chronic diseases, the need for accurate dosing, and advancements in biopharmaceuticals.

Moreover, the nasal segment encompasses medications delivered through nasal sprays or inhalers. Pharmaceutical glass packaging in the nasal segment provides protection against light, moisture, and oxygen, preserving the integrity and efficacy of nasal medications. The growing prevalence of respiratory diseases and the demand for convenient and precise nasal drug delivery contribute to the expansion of this segment.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa.

The pharmaceutical industry in North America, particularly in the United States, is well-established and technologically advanced. The region has a high demand for pharmaceutical glass packaging due to robust healthcare infrastructure, a large consumer base, and stringent regulatory standards. Additionally, the increasing focus on patient safety and the need for reliable packaging solutions contribute to the growth of the North American market.

Furthermore, the Asia Pacific region is witnessing rapid growth in the pharmaceutical industry, driven by factors such as a large population, rising healthcare expenditure, and increasing generic drug manufacturing. Countries like China and India are emerging as major players in the pharmaceutical sector, leading to a surge in demand for pharmaceutical glass packaging. The region's growing middle-class population, urbanization, and expanding healthcare access further contribute to the market growth. Additionally, the rising emphasis on product safety, advancements in drug manufacturing technologies, and the adoption of international quality standards fuel the demand for pharmaceutical glass packaging in Asia.

Competitive Landscape:

Top companies play a crucial role in driving the growth of the market through their innovative solutions, extensive product portfolios, and strong market presence. These companies invest heavily in research and development to introduce advanced glass packaging technologies that cater to the evolving needs of the pharmaceutical industry. They continuously enhance the barrier properties, durability, and design of their glass containers to ensure optimal protection and preservation of pharmaceutical products. Moreover, these companies focus on providing a wide range of customization options, such as different sizes, shapes, closures, and labeling solutions, to meet the specific requirements of pharmaceutical companies. This flexibility allows pharmaceutical manufacturers to package their products efficiently while maintaining brand identity and complying with regulatory standards. Additionally, through collaborations and partnerships, top companies establish strong relationships with pharmaceutical manufacturers. They provide comprehensive packaging solutions, including design consultation, supply chain management, and technical support, which contribute to the growth of the market by offering integrated and streamlined packaging services. Furthermore, these companies actively engage in sustainability initiatives, promoting eco-friendly glass packaging solutions. By prioritizing recyclability, they align with the growing consumer and industry demand for environmentally responsible packaging options.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Ardagh Group S.A

Beatson Clark

Bormioli Pharma S.p.A.

Corning Incorporated

Gerresheimer AG

Nipro Corporation

Piramal Enterprises Ltd.

Schott AG

SGD Pharma

Shandong Pharmaceutical Glass Co. Ltd.

Sisecam (Turkiye Is Bankasi A.S.)

Stolzle-Oberglas GmBH

West Pharmaceutical Services Inc.

Recent Developments:

In 2020, Ardagh Group S.A., a leading global packaging company, collaborated with B.D. (Becton, Dickinson, and Company), a global medical technology company to develop and supply high-quality glass vials for COVID-19 vaccines. This collaboration aimed to support global vaccination efforts by providing secure and reliable vaccine packaging solutions.

In 2021, Beatson Clark, a UK-based glass packaging manufacturer, announced an investment of £2 million in its glass production facility to expand its pharmaceutical glass packaging capabilities. This investment allowed Beatson Clark to enhance its manufacturing processes, increase production capacity, and introduce advanced technologies for pharmaceutical glass packaging.

In 2019, Bormioli Pharma S.p.A, an Italian company specializing in pharmaceutical glass packaging, launched an advanced glass container called "Type I Plus" to address the specific needs of sensitive pharmaceutical products. The Type I Plus glass offers enhanced chemical resistance and protection against delamination, making it suitable for storing and preserving highly reactive medications.

Key Questions Answered in This Report

  • 1. What was the size of the global pharmaceutical glass packaging market in 2023?
  • 2. What is the expected growth rate of the global pharmaceutical glass packaging market during 2024-2032?
  • 3. What are the key factors driving the global pharmaceutical glass packaging market?
  • 4. What has been the impact of COVID-19 on the global pharmaceutical glass packaging market?
  • 5. What is the breakup of the global pharmaceutical glass packaging market based on the product?
  • 6. What is the breakup of the global pharmaceutical glass packaging market based on the drug type?
  • 7. What are the key regions in the global pharmaceutical glass packaging market?
  • 8. Who are the key players/companies in the global pharmaceutical glass packaging market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Pharmaceutical Glass Packaging Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Bottles
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Vials
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Ampoules
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Cartridges and Syringes
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Drug Type

  • 7.1 Generic
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Branded
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Biologic
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Oral
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Injectable
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Nasal
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Ardagh Group S.A
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Beatson Clark
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Bormioli Pharma S.p.A.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Corning Incorporated
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Gerresheimer AG
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
    • 14.3.6 Nipro Corporation
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Piramal Enterprises Ltd.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Schott AG
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 SWOT Analysis
    • 14.3.9 SGD Pharma
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Shandong Pharmaceutical Glass Co. Ltd.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
    • 14.3.11 Sisecam (Turkiye Is Bankasi A.S.)
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
    • 14.3.12 Stolzle-Oberglas GmBH
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
    • 14.3.13 West Pharmaceutical Services Inc.
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials
      • 14.3.13.4 SWOT Analysis